Society Advocates to Medicare about Physician Payment and Telehealth

The Endocrine Society continues to advocate for physician payment and telehealth policies important to Society members.

In September, the Society submitted comments on the Medicare Physician Fee Schedule (MPFS) proposed rule for calendar year 2022. This annual rule updates payment policies and payment rates for Part B services furnished under the MPFS. In our letter, we provided comments on a wide range of policies proposed under the rule including the need for expanded access to telehealth services. We urged CMS to work towards making coverage of audio-only services permanent by releasing the utilization data that has been gathered on audio-only during the public health emergency (PHE). Releasing this data will help the Society work with CMS to address fraud and abuse concerns which have prevented expansion of audio-only telehealth.

In addition to telehealth, we also urged CMS to re-evaluate their proposed changes to practice expense (PE) values which will impact a wide range of services commonly billed by endocrinologists. The changes proposed under the rule could result in decreases to services such as traditional continuous glucose monitoring and fine needle aspiration. Society staff worked closely with the Clinical Affairs Core Committee (CACC) in drafting our comments. The proposed rule is expected to be finalized later this year and we will share an update with you when the final rule is published. In the meantime, if you’re interested in reading our comment letter, please visit the Society Letters page.

You may also like

  • House Announces New Caucus Focused on Social Determinants of Health

    The House of Representatives announced the formation of a new Social Determinants of Health (SDOH) Caucus. The Caucus will explore opportunities to improve the impact of current services delivered to address social determinants with the support of federal funding and maximize existing and future federal investments in health, food, housing, transportation, and other important drivers…

  • Drug Pricing and Affordable Insulin Issues Take Precedence

    Action on drug pricing and access to affordable insulin has heated up in Congress as part of the consideration of a large budget reconciliation process. The Endocrine Society has been a leading advocate urging the Biden Administration and Congress to take action on drug pricing and has offered several policy recommendations, including allowing the government…

Find more in